FOLH1 and neoplasm: The tumor-to-blood ratios were increased at low molar amounts of injected ligand in the PC-3 PIP mouse model when using [177Lu]Lu-Ibu-DAB-PSMA, but an opposite trend was observed for [177Lu]Lu-PSMA-617 (Fig. 4c/d).